Health Highlights: April 13, 2018

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Mental Health Does Not Come With A Manual, It Comes With Friends & Family Support That Never Gives Up!
Join now

Limit Alcohol To One Drink a Day: Study

A new study says adults should limit their alcohol consumption to one drink a day, which is lower than drinking guidelines in the U.S. and many other countries.

The researchers warned that adults who exceed the one-drink-a-day limit can expect to die at a younger age than those who do not, the Associated Press reported.

Current U.S. guidelines recommend no more than seven drinks a week for women, but 14 drinks a week for men, the Associated Press reported.

A 40-year-old man who drinks as much as the U.S. guidelines allow could expect to live one to two years less than one who has a maximum of seven drinks a week, according to the study in the Lancet medical journal.

The researchers analyzed 83 studies that were conducted in 19 countries and included nearly 600,000 people who drank alcohol.

"What this is saying is, if you're really concerned about your longevity, don't have more than a drink a day," David Jernigan, an alcohol researcher at Johns Hopkins University who was not involved in the study, told the AP.

-----

Canadian Online Pharmacy Faces $34 Million in Fines

An online pharmacy called Canada Drugs faces $34 million in fines under a plea deal made with U.S. prosecutors.

They say the international company illegally imported unapproved and misbranded drugs from all over the world, the Associated Press reported.

Canada Drugs has made at least $78 million through illegal drug imports, including fake versions of the cancer drugs Avastin and Altuzan that had no active ingredients, according to prosecutors.

They spent more than two years trying to get the company to appear in U.S. court to face felony charges, finally securing a plea deal late last year, the AP reported.

On Friday, a judge will decide whether to approve the prosecutors' recommended sentences of $29 million forfeited, $5 million in fines and five years' probation for the company, and six months' house arrest, five years' probation and a $250,000 fine for company founder Kristian Thorkelson.

Under the deal, Canada Drugs would permanently halt sales of all unapproved, misbranded and counterfeit drugs and would surrender all the domain names of the numerous websites it used to sell drugs, the AP reported.

The Internet's Most Trusted Source For Mental Health Information
Sign up

The final decision on the sentences is up to U.S. District Judge Dana Christensen. An advocacy group says the plea deal terms are too lenient and wants the judge to impose more severe penalties to deter similar crimes in the future.


Copyright © 2013-2018 HealthDay. All rights reserved.


Related Content

Understanding the Anxious Self: An Original Series on Anxiety Disorder
Understanding the Anxious Self: An Original Series on Anxiety Disorder

Anxiety disorder affects 40 million adults in the U.S., making it the most commo...

Read more
New Series: Understanding the Anxious Self
New Series: Understanding the Anxious Self

Access all 7 episodes of our first video series instantly on Oct 15....

Read more
Dr. Ramani on Why Talk Therapy Is so Important
Dr. Ramani on Why Talk Therapy Is so Important

Have you tried talk therapy? A lot of people think talk therapy is a waste of ti...

Read more
Road Rage: The Psychology Behind It & How to Prevent It
Road Rage: The Psychology Behind It & How to Prevent It

Road rage: it’s a feeling we all know too well. But does it have more serious me...

Read more
How Does Borderline Personality Disorder Look in Men vs. Women?
How Does Borderline Personality Disorder Look in Men vs. Women?

She's booked out three months in advance, but we got a rare chance to sit down w...

Read more
Researchers Want Doctors To Be Able To Prescribe Magic Mushrooms For Depression
Researchers Want Doctors To Be Able To Prescribe Magic Mushrooms For Depression

Researchers at Johns Hopkins University think it’s time to change the drug class...

Read more